Literature DB >> 12466035

Cytokines as a stressor: implications for depressive illness.

Hymie Anisman1, Shawn Hayley, Nicolas Turrin, Zul Merali.   

Abstract

Stressful events have been implicated in the provocation of depressive illness. Inasmuch as immunological challenge, and particularly cytokine administration, engender neuroendocrine and central neurochemical changes reminiscent of those provoked by psychogenic stressors, it was suggested that immune activation may also contribute to affective illness. The present report provides a brief overview of the neurochemical sequelae of acute and repeated interleukin-1beta (IL-1beta), tumour necrosis factor-alpha (TNF-alpha) and IL-2 treatment, describes some of the synergisms associated with these treatments, as well as their potential interactions with psychogenic stressors. In addition, a discussion is provided concerning the fact that cytokines, like stressors, may have time-dependent proactive effects, so that re-exposure to the treatments provoke greatly augmented neurochemical changes (sensitization). Given that the effects of cytokines are evident within hypothalamic, as well as extrahypothalamic sites, including various limbic regions, it is suggested that cytokines may impact on emotional changes, including depression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466035     DOI: 10.1017/S1461145702003097

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  29 in total

1.  Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine.

Authors:  Peggy Jungke; Gigi Ostrow; Jian-Liang Li; Sharon Norton; Karen Nieber; Olaf Kelber; Veronika Butterweck
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

Review 2.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

3.  Effect of Schisandra chinensis on interleukins, glucose metabolism, and pituitary-adrenal and gonadal axis in rats under strenuous swimming exercise.

Authors:  Jie Li; Jian Wang; Jia-Qing Shao; Hong Du; Yang-Tian Wang; Li Peng
Journal:  Chin J Integr Med       Date:  2014-08-20       Impact factor: 1.978

Review 4.  Trauma-induced systemic inflammatory response versus exercise-induced immunomodulatory effects.

Authors:  Elvira Fehrenbach; Marion E Schneider
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  [Elevated postoperative pain levels following orthopedic surgery. Depression as a strong predictor].

Authors:  S Goebel; B Baumann; A Steinert; S Reppenhagen; H Faller
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

6.  Body affects mind? Preoperative behavioral and biological predictors for postoperative symptoms in mental health.

Authors:  Amy L Ai; Mohamed Kabbaj; Lee L Kathy
Journal:  J Behav Med       Date:  2012-12-29

7.  Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Simone Gantz; Marcus Schiltenwolf; Wiltrud Richter
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

8.  Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination.

Authors:  Daniella Urbach-Ross; Alexander W Kusnecov
Journal:  Brain Behav Immun       Date:  2007-05-08       Impact factor: 7.217

Review 9.  A final common pathway for depression? Progress toward a general conceptual framework.

Authors:  Eric A Stone; Yan Lin; David Quartermain
Journal:  Neurosci Biobehav Rev       Date:  2007-10-10       Impact factor: 8.989

10.  Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory.

Authors:  Ja Wook Koo; Ronald S Duman
Journal:  Neurosci Lett       Date:  2009-03-27       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.